Leads research at the interface of neurodegeneration, proteomics, and neuropathology, using brain, CSF, and plasma profiling with network modeling to subtype disease, discover biomarkers, and evaluate therapeutic response across Alzheimer’s, ALS, and related dementias, including diverse populations.